Suchergebnisse - "Gorman, Donal N"

PubPharm (13)

1

Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes

enthalten in: Journal of clinical pharmacology | 2024

von Fediuk, D. | Gorman, D. | Stoddard, S. | +4

2

Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes

enthalten in: The Journal of Clinical Pharmacology | 2024

von Fediuk, D. | Gorman, D. | Stoddard, S. | +4

3

Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes : A 12-week, randomized, placebo-controlled, Phase 2 study comparing different dose-escalation schemes

enthalten in: Diabetes, obesity & metabolism | 2023

von Saxena, A. | Frias, J. | Gorman, D. | +4

4

Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes : A Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Saxena, A. | Frias, J. | Brown, L. | +4

5

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF-06882961), an oral small-molecule glucagon-like peptide-1 receptor agonist, in Japanese adults with type 2 diabetes mellitus

enthalten in: Diabetes, obesity & metabolism | 2023

von Ono, R. | Furihata, K. | Ichikawa, Y. | +4

6

Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes : A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes

enthalten in: Diabetes, Obesity and Metabolism | 2023

von Saxena, A. | Frias, J. | Gorman, D. | +4

7

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron ( PF‐06882961), an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, in Japanese adults with type 2 diabetes mellitus

enthalten in: Diabetes, Obesity and Metabolism | 2023

von Ono, R. | Furihata, K. | Ichikawa, Y. | +4

8

Danuglipron (PF-06882961) in type 2 diabetes : a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

enthalten in: Nature medicine | 2021

von Saxena, A. | Gorman, D. | Esquejo, R. | +5

CommentIn: Nat Med. 2021 Jun;27(6):952-953. - PMID 34127851

9

Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions

enthalten in: PloS one | 2014

von Burgess, S. | Freitag, D. | Khan, H. | +2

10

Interleukin-6 receptor pathways in coronary heart disease : a collaborative meta-analysis of 82 studies

enthalten in: Lancet (London, England) | 2012

von IL6R Genetics Consortium Emerging Risk Factors Collaboration | Sarwar, N. | Butterworth, A. | +194

CommentIn: Lancet. 2012 Mar 31;379(9822):1176-8. - PMID 22421338